
News|Articles|February 26, 2008
GAO: Part D plan sponsors can improve their drug coverage performance
A new Government Accountability Office report concludes that some Medicare Part D drug plan sponsors are dragging their feet when notifying beneficiaries of their drug coverage decisions.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
Experts Urge Pneumococcal Vaccination for Older Patients With Chronic Respiratory Disease
5




























